APPLICATION
NDA021708
TYPE
NDA
ORIGINAL APPROVAL
2006-02-27
LATEST ACTION
2006-02-27
ROUTE
TRANSDERMAL
DOSAGE FORM
SYSTEM
MARKETING STATUS
Prescription
Products
EMSAMPrescription
SELEGILINE 9MG · SYSTEM · TRANSDERMAL
EMSAMPrescription
SELEGILINE 12MG · SYSTEM · TRANSDERMAL
EMSAMPrescription
SELEGILINE 6MG · SYSTEM · TRANSDERMAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.